Spots Global Cancer Trial Database for cancer
Every month we try and update this database with for cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients | NCT00342485 | Cell Function | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML) | NCT00486265 | Acute Myelogeno... | AZD4877 | 18 Years - | AstraZeneca | |
| Enteral Nutrition in Cancer Patients | NCT01304446 | Malnutrition Cancer | industrialized ... | 1 Year - | Grupo de Apoio ao Adolescente e a Crianca com Cancer | |
| Preoperative Localisation of the Sentinel Lymph Node in Breast Cancer | NCT01154972 | Breast Cancer | Preoperative se... | - | NHS Tayside | |
| Qigong for Pre-frail and Frail Older Cancer Survivors | NCT04694066 | Cancer Frailty | Qigong Light flexibili... | 65 Years - 85 Years | The University of Hong Kong | |
| Testing and Evaluating the Collection of Patient Reported Outcomes In Cancer Care Using Innovative Approaches | NCT05911672 | Cancer | PRICE | 18 Years - 100 Years | Cyprus University of Technology | |
| Serial Testing To Assess Cognitive Function In Cancer | NCT06160700 | Cancer | Montreal Cognit... | 18 Years - | Indiana University | |
| Polymorphisms in the Vitamin D System and Health | NCT01395303 | Infarction Stroke Diabetes Fracture Aortic Stenosis Cancer Death | 30 Years - 90 Years | University of Tromso | ||
| Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport | NCT01733342 | Cancer | Celsite chemopo... local anesthesi... Humanport chemo... | 20 Years - | Seoul National University Hospital | |
| Safety Study of Two Oral Formulations of MGCD265 Administered in Healthy Subjects in the Fasting State | NCT01930006 | Advanced Malign... | MGCD265 | 18 Years - 55 Years | Mirati Therapeutics Inc. | |
| Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma | NCT00110994 | Cancer Melanoma | Sorafenib (Nexa... Placebo Dacarbazine | 18 Years - | Bayer | |
| Effectiveness of Mobile Based Monitoring System in the Management of Chemotherapy-Related Symptoms | NCT05946070 | Cancer Chemotherapeuti... Mobile Applicat... | ONKOSIS | 18 Years - | Istanbul University - Cerrahpasa (IUC) | |
| Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma | NCT06279767 | Glioblastoma Cancer Temozolomide | 6-mercaptopurin... | 18 Years - 65 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Use of Heart Rate Variability (HRV) Biofeedback for Cancer Survivors | NCT03692624 | Cancer | Biofeedback | 18 Years - | Prisma Health-Upstate | |
| Post-Operative Ambulatory Challenge and Exercise (PACE) Trial | NCT03234933 | Cancer | Mobility Tracke... | 18 Years - | Dana-Farber Cancer Institute | |
| A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss | NCT00094562 | Cancer Cancer Cachexia Chronic Obstruc... Chronic Heart F... Rheumatoid Arth... | Fish oil supple... | 18 Years - 90 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice | NCT05694013 | Cancer | Roche DPM Modul... Atezolizumab SC Local SOC suppo... | 18 Years - | Hoffmann-La Roche | |
| Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound | NCT02218242 | Lung Cancer | Intraoperative ... | 18 Years - | University of Kentucky | |
| Physicians Survey on Genetic Testing | NCT00341107 | Cancer | - | National Institutes of Health Clinical Center (CC) | ||
| Personalised Exercise Rehabilitation for Cancer Survivorship | NCT05615285 | Cancer | PERCS Triage an... | 18 Years - | University of Dublin, Trinity College | |
| Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies | NCT05707325 | Cancer Solid Tumor Hematologic Mal... | engineered red ... | 18 Years - 75 Years | Westlake Therapeutics | |
| Phase II Trial for Large ER-Negative Breast Cancers | NCT01869192 | Malignant Neopl... | Epirubicin Cyclophosphamid... Docetaxel Capecitabine Radiation Thera... | 18 Years - | University of Colorado, Denver | |
| The Effect of the Program on the Awareness of Roma Women on Cervical Cancer | NCT04756440 | Cervical Cancer | Education Progr... | 30 Years - 65 Years | Ondokuz Mayıs University | |
| MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers | NCT02989064 | Urothelial Carc... Head and Neck C... Melanoma Bladder Urothel... | Autologous gene... | 18 Years - 75 Years | Adaptimmune | |
| Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma | NCT00051545 | Liver Neoplasms | Seocalcitol | 18 Years - 75 Years | LEO Pharma | |
| An Adaptive Dyadic Self-directed Coping and Self-management Skills Training Intervention for Caregivers of Individuals With Cancer | NCT04255030 | Cancer Anxiety | Coping Together... Lay telephone c... Motivational In... | 18 Years - | St. Mary's Research Center, Canada | |
| A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas | NCT01188096 | Brain Tumors | Poly ICLC | - 21 Years | Wake Forest University Health Sciences | |
| Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer | NCT01416038 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | DPX-Survivac low dose cyclop... | 18 Years - | ImmunoVaccine Technologies, Inc. (IMV Inc.) | |
| A Study of Physical Activity in Cancer Survivors | NCT05988892 | Cancer | Physical Activi... | 18 Years - | Mayo Clinic | |
| Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | NCT00116441 | Multiple Myelom... | Therapeutic Cel... | 18 Years - 70 Years | Cell Genesys | |
| Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies | NCT01690741 | Cancer | Nerofe | 18 Years - | Immune System Key Ltd | |
| Wilderness Program for Adolescent and Young Adult Cancer Survivors | NCT04761042 | Cancer | WAYA-Wilderness WAYA-Holiday | 16 Years - 39 Years | Mid Sweden University | |
| A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma | NCT03470922 | Melanoma | Relatlimab Nivolumab | 12 Years - | Bristol-Myers Squibb | |
| Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin | NCT01093690 | Cancer | metoclopramide placebo | 18 Years - | Mahidol University | |
| Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors | NCT04875871 | Cancer | Particle radiot... Magnetic resona... Computertomogra... Copper-64-Diace... 18-F-FluorDesox... Blood sampling | 18 Years - | EBG MedAustron GmbH | |
| Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer | NCT01538563 | Solid Tumors Advanced Cancer Cancer Neoplasms | rigosertib sodi... | 18 Years - | Traws Pharma, Inc. | |
| Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer | NCT02810457 | Carcinoma, Non-... | FKB238 (bevaciz... Avastin (bevaci... Paclitaxel Carboplatin | 18 Years - | Centus Biotherapeutics Limited | |
| Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer | NCT04522804 | Cancer | Psilocybin | 25 Years - | University of Utah | |
| Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management | NCT04626830 | Cancer Adherence to Me... Symptom Managem... | Mobile Applicat... | 18 Years - | Baskent University | |
| Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) | NCT01160094 | Cancer | Treatment | 18 Years - | Novartis | |
| Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs | NCT01871519 | Compression Fra... Osteoporosis Cancer | Balloon kyphopl... | 65 Years - | Medtronic Spinal and Biologics | |
| Thiopurine Methyltransferase Polymorphisms Evaluation | NCT00166647 | Cancer | Blood Sampling | - 18 Years | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |
| Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety | NCT00302744 | Anxiety | Psilocybin (dru... Niacin MRI | 18 Years - 70 Years | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | |
| Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients | NCT00693173 | Anal Cancer | 18 Years - 80 Years | The University of Texas Medical Branch, Galveston | ||
| Clinical Tumor Anemia Registry (TAR) | NCT01795690 | Anemia | 18 Years - | iOMEDICO AG | ||
| A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors | NCT01231594 | Cancer | GSK2118436 GSK1120212 Other approved ... | 18 Years - | Novartis | |
| Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients. | NCT02315768 | Chronic Lymphoc... | GA101 ibrutinib | 65 Years - | University of California, San Diego | |
| Neuropathic Pain in Patients With Cancer | NCT00474916 | Neuropathic Pai... | KRN5500 Placebo | 18 Years - | DARA Therapeutics | |
| Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma | NCT00847522 | Cancer | Fluorescein | 18 Years - | University of Utah | |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Cancer & Chemotherapy Symptom Management Using an Automated Telephone Reporting System | NCT01979146 | Cancer | Provider Unreli... | 18 Years - | University of Utah | |
| Sarcopenia and Risk of Falls in Patients With Major Chronic Diseases | NCT03798418 | Stroke Osteoporosis Chronic Kidney ... Cancer | elastic band st... diet counseling | - | Changhua Christian Hospital | |
| Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin | NCT01093690 | Cancer | metoclopramide placebo | 18 Years - | Mahidol University | |
| Study of TRC102 in Combination With Pemetrexed in Cancer Patients | NCT00692159 | Neoplasm | TRC102 + pemetr... | 18 Years - | Tracon Pharmaceuticals Inc. | |
| Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy | NCT04957511 | Gynecologic Can... Immunotherapy Gut Microbiome | 18 Years - | Viome | ||
| Somatic Acupressure for Symptom Cluster Management in Breast Cancer Patients | NCT04118140 | Cancer | Somatic Acupres... Sham acupressur... Usual care | 18 Years - | Charles Darwin University | |
| AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) | NCT00122343 | Endometrial Can... | ridaforolimus | 18 Years - | Merck Sharp & Dohme LLC | |
| Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma | NCT01348919 | Multiple Myelom... | CEP-18770 Lenalidomide Dexamethasone | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer | NCT02579811 | Metastatic Rena... | Axitinib | 18 Years - | Case Comprehensive Cancer Center | |
| Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients | NCT00628043 | Anemia | epoetin beta placebo | 20 Years - 79 Years | Chugai Pharmaceutical | |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | NCT00600496 | Breast Cancer Breast Neoplasm... Colon Cancer Colonic Cancer Colon Neoplasms Lung Cancer Melanoma Kidney Cancer | AZD6244 Dacarbazine Erlotinib Docetaxel Temsirolimus | 18 Years - 130 Years | AstraZeneca | |
| Assessment of Patient Satisfaction in Palliative Cancer When They Return Home After Hospitalization in Palliative Care | NCT02207543 | Cancer Palliative Care Home | Medical telepho... | 18 Years - | Centre Francois Baclesse | |
| Collaborative Care Intervention for Cancer Caregivers | NCT02944136 | Depression Advanced Cancer | enhanced usual ... stepped collabo... | 21 Years - | University of Pittsburgh | |
| Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma | NCT01233375 | Metastatic Panc... | CO-1.01 | 18 Years - | Clovis Oncology, Inc. | |
| m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients | NCT03634696 | Cancer | mPCL Usual Care | 21 Years - | MaineHealth | |
| Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer | NCT03347162 | Cancer Cancer of Pancr... Cancer of Liver Cancer of Esoph... Cancer of Stoma... Cancer, Metasta... | 18 Years - | Rigshospitalet, Denmark | ||
| Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | NCT04301362 | Cancer Thromboembolism Thrombosis Biomarkers | Thrombosis biom... | 18 Years - | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | |
| Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors | NCT04916249 | Cancer Remission | Tibetree Pain R... Placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | NCT00496236 | Head and Neck C... Head and Neck N... | TNFerade biolog... | 18 Years - | GenVec | |
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | NCT01846429 | Tumor Cancer Pain Malignant Solid... Unresectable Ma... Hematologic Mal... Multiple Myelom... Lymphoma Neoplasm Metast... | Sodium Bicarbon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Validation of a Screening Scale for Misuse of Opioid Analgesics | NCT05761587 | Cancer Pain Opioid Analgesi... | Questionnaires | 18 Years - | University Hospital, Clermont-Ferrand | |
| Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations | NCT05876806 | Cancer | Dabrafenib Trametinib | 19 Years - | Seoul St. Mary's Hospital | |
| Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis (VRH) in a Clinical Population | NCT05362708 | Cancer | Clinical - Hypn... | 18 Years - 65 Years | University of Liege | |
| Peer Support Dyads in Churches | NCT03463941 | Peer Support an... Obesity Type II Diabete... Cardiovascular ... Cancer | Peer Support Dy... | 18 Years - | Duke University | |
| A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors | NCT00437736 | Cancer | APO010 | 18 Years - | Valerio Therapeutics | |
| Economic Analyses of the REDUCE Trial | NCT01337258 | Neoplasms, Pros... Benign Prostati... Cancer | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer | NCT00504790 | Cancer | GSK923295 | 18 Years - | GlaxoSmithKline | |
| Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors | NCT05361954 | Cancer Cancer of Pancr... Sarcoma Hepatic Metasta... Solid Tumor | STI-1386 | 18 Years - | Sorrento Therapeutics, Inc. | |
| Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer | NCT01046461 | Solid Tumour Postoperative N... | Ramosetron, Apr... | 18 Years - 75 Years | Hallym University Medical Center | |
| Analgesia for Laparotomy in Cancer Patients: Quadratus Lumborum Block | NCT03328390 | Cancer | Quadratus lumbo... Transversus abd... | 20 Years - 60 Years | Mansoura University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
